CD91.DE vs. BNQL.DE

Last updated Jun 5, 2026

CD91.DE (Amundi NYSE Arca Gold Bugs UCITS ETF Dist) and BNQL.DE (BNP Paribas Palladium ETC) are both exchange-traded funds - CD91.DE is a Gold fund tracking the NYSE Arca Gold BUGS, while BNQL.DE is a Precious Metals fund tracking the Palladium Spot Price. Both are passively managed. Over the past 5 years, CD91.DE returned 20.17%/yr vs -14.19%/yr for BNQL.DE. At a 0.33 correlation, their price movements are largely independent. CD91.DE charges 0.65%/yr vs 0.99%/yr for BNQL.DE.

Performance

CD91.DE vs. BNQL.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Amundi NYSE Arca Gold Bugs UCITS ETF Dist (CD91.DE) and BNP Paribas Palladium ETC (BNQL.DE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CD91.DE achieves a 2.09% return, which is significantly higher than BNQL.DE's -17.76% return.

CD91.DE

• 1D: 0.92%
• 1M: -0.47%
• YTD: 2.09%
• 6M: 9.79%
• 1Y: 67.95%
• 3Y*: 40.18%
• 5Y*: 20.17%
• 10Y*: 12.49%

BNQL.DE

• 1D: -1.06%
• 1M: -11.56%
• YTD: -17.76%
• 6M: -8.41%
• 1Y: 29.07%
• 3Y*: -5.67%
• 5Y*: -14.19%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CD91.DE vs. BNQL.DE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CD91.DE Amundi NYSE Arca Gold Bugs UCITS ETF Dist	2.09%	132.40%	20.73%	2.42%	-1.60%	-8.06%	15.38%	49.81%	-12.27%	-11.24%
BNQL.DE BNP Paribas Palladium ETC	-17.76%	58.42%	-16.10%	-40.26%	-4.34%	-10.11%	10.43%	53.40%	21.86%	38.20%

Correlation

The correlation between CD91.DE and BNQL.DE is 0.46, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.46
Correlation (3Y) Calculated over the trailing 3-year period	0.41
Correlation (5Y) Calculated over the trailing 5-year period	0.40
Correlation (All Time) Calculated using the full available price history since Dec 12, 2016	0.33

The correlation between CD91.DE and BNQL.DE shifts across timeframes, from 0.33 (all time) to 0.46 (1 year), reflecting how their relationship changes across market environments.

Return for Risk

CD91.DE vs. BNQL.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CD91.DE

CD91.DE Risk / Return Rank: 44
CD91.DE Sharpe Ratio Rank: 46
CD91.DE Sortino Ratio Rank: 41
CD91.DE Omega Ratio Rank: 42
CD91.DE Calmar Ratio Rank: 51
CD91.DE Martin Ratio Rank: 40

BNQL.DE

BNQL.DE Risk / Return Rank: 20
BNQL.DE Sharpe Ratio Rank: 19
BNQL.DE Sortino Ratio Rank: 22
BNQL.DE Omega Ratio Rank: 22
BNQL.DE Calmar Ratio Rank: 19
BNQL.DE Martin Ratio Rank: 17

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CD91.DE vs. BNQL.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amundi NYSE Arca Gold Bugs UCITS ETF Dist (CD91.DE) and BNP Paribas Palladium ETC (BNQL.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CD91.DE	BNQL.DE	Difference
Sharpe ratio: Return per unit of total volatility	1.60	0.63	+0.97
Sortino ratio: Return per unit of downside risk	2.06	1.14	+0.92
Omega ratio: Gain probability vs. loss probability	1.27	1.14	+0.13
Calmar ratio: Return relative to maximum drawdown	2.49	0.78	+1.71
Martin ratio: Return relative to average drawdown	6.17	1.68	+4.50
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CD91.DE vs. BNQL.DE - Sharpe Ratio Comparison

The current CD91.DE Sharpe Ratio is 1.60, which is higher than the BNQL.DE Sharpe Ratio of 0.63. The chart below compares the historical Sharpe Ratios of CD91.DE and BNQL.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CD91.DE	BNQL.DE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.60	0.63	+0.97
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.58	-0.31	+0.89
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.36	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.09	0.11	-0.02

Drawdowns

CD91.DE vs. BNQL.DE - Drawdown Comparison

The maximum CD91.DE drawdown since its inception was -80.32%, which is greater than BNQL.DE's maximum drawdown of -73.80%. Use the drawdown chart below to compare losses from any high point for CD91.DE and BNQL.DE.

Drawdown Indicators

	CD91.DE	BNQL.DE	Difference
Max Drawdown Largest peak-to-trough decline	-80.32%	-73.80%	-6.52%
Max Drawdown (1Y) Largest decline over 1 year	-27.16%	-37.28%	+10.12%
Max Drawdown (3Y) Largest decline over 3 years	-27.16%	-43.58%	+16.42%
Max Drawdown (5Y) Largest decline over 5 years	-39.56%	-73.80%	+34.24%
Max Drawdown (10Y) Largest decline over 10 years	-55.46%	—	—
Current Drawdown Current decline from peak	-23.41%	-61.09%	+37.68%
Average Drawdown Average peak-to-trough decline	-46.60%	-32.15%	-14.45%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.95%	17.30%	-6.35%

Volatility

CD91.DE vs. BNQL.DE - Volatility Comparison

Amundi NYSE Arca Gold Bugs UCITS ETF Dist (CD91.DE) has a higher volatility of 13.40% compared to BNP Paribas Palladium ETC (BNQL.DE) at 10.31%. This indicates that CD91.DE's price experiences larger fluctuations and is considered to be riskier than BNQL.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CD91.DE	BNQL.DE	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.40%	10.31%	+3.09%
Volatility (6M) Calculated over the trailing 6-month period	33.89%	37.75%	-3.86%
Volatility (1Y) Calculated over the trailing 1-year period	42.29%	45.71%	-3.42%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	34.31%	45.30%	-10.99%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	34.40%	40.77%	-6.37%

CD91.DE vs. BNQL.DE - Expense Ratio Comparison

CD91.DE has a 0.65% expense ratio, which is lower than BNQL.DE's 0.99% expense ratio.

Dividends

CD91.DE vs. BNQL.DE - Dividend Comparison

CD91.DE's dividend yield for the trailing twelve months is around 0.13%, while BNQL.DE has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
BNQL.DE BNP Paribas Palladium ETC	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
CD91.DE Amundi NYSE Arca Gold Bugs UCITS ETF Dist	0.13%	0.14%	0.31%	2.37%	1.05%	0.46%	0.14%	0.30%	0.00%	0.57%

Frequently Asked Questions

Can I hold both CD91.DE and BNQL.DE in my portfolio?

CD91.DE and BNQL.DE have a correlation of 0.46, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, CD91.DE or BNQL.DE?

On fees, CD91.DE is cheaper at 0.65% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CD91.DE or BNQL.DE?

CD91.DE is cheaper with a 0.65% expense ratio, compared with 0.99% for BNQL.DE.

What is the main difference between CD91.DE and BNQL.DE?

CD91.DE is categorized as Gold, while BNQL.DE is Precious Metals. CD91.DE tracks NYSE Arca Gold BUGS, while BNQL.DE tracks Palladium Spot Price. They also come from different issuers: Amundi and BNP Paribas. Their fees differ too: 0.65% for CD91.DE and 0.99% for BNQL.DE.